The decision by a Texas judge to overturn F.D.A. approval for the abortion pill mifepristone could upend the pharmaceutical industry.
Why Drugmakers’ Abortion Pill Battle is Such a Big Deal
Written by
in
Credit Suisse Group AG, Decisions and Verdicts, Doerr, John, Federal Reserve Bank of New York, Federal Reserve System, Food and Drug Administration, Gershkovich, Evan, Home Box Office, internal-storyline-no, Kacsmaryk, Matthew, Moritz, Michael Jonathan, Musk, Elon, Newsom, Gavin, Ocasio-Cortez, Alexandria, Regulation and Deregulation of Industry, Silicon Valley Bank, Supreme Court (US), Tesla Motors Inc, Twitter, UBS AG, Warner Bros Discovery, Warner Media LLC